Published in Hospital and Nursing Home Week, August 10th, 2006
Study 1: HAART-associated facial lipoatrophy is corrected by polylactic acid implants.
In a recent report published in the journal Archives of Dermatology, researchers in Italy conducted a study to "assess the efficacy, safety, and tolerability of facial injections of polylactic acid for human immunodeficiency virus (HIV) 1-associated facial lipoatrophy, which commonly affects HIV-1-infected patients receiving combination antiretroviral therapy.
"A cohort of 50 consecutive HIV-1-infected outpatients with moderate to severe facial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.